MedPath

Sera application in leprosy patients

Not Applicable
Completed
Conditions
Health Condition 1: null- Dry eye patients of Hansens disease
Registration Number
CTRI/2013/07/003802
Lead Sponsor
Regional Institute of ophthalmology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
102
Inclusion Criteria

both sexes of patients of Hansen disease of age group 23yr to 75 yr were enrolled

Exclusion Criteria

Patients(both sexes) having active ocular and lid infection, active keartitis , lid deformity, history of punctual occlusion within last three months, pregnancy and lactation, were excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate comparative efficacy of topically applied 20% umbilical cord blood serum (UBS) and 20% autologous serum (ALS) with preservative free artificial tear drop (AT) in moderate to severe dry patients of Hansenâ??s disease along with change in tear protein profile.Timepoint: 21/04/2011
Secondary Outcome Measures
NameTimeMethod
nilTimepoint: none
© Copyright 2025. All Rights Reserved by MedPath